Carlos Blanco1, Claudia Rafful, Mark Olfson. 1. Department of Psychiatry, New York State Psychiatric Institute, Columbia University, New York, NY 10032, USA. Cblanco@nyspi.columbia.edu
Abstract
OBJECTIVES: A large body of comparative effectiveness research (CER) focuses on the use of observational and quasi-experimental approaches. We sought to examine the use of clinical trials as a tool for CER, particularly in mental health. STUDY DESIGN AND SETTING: Examination of three ongoing randomized clinical trials in psychiatry addressing issues that would pose difficulties for nonexperimental CER methods. RESULTS: Existing statistical approaches to nonexperimental data appear insufficient to compensate for biases that may arise when the pattern of missing data cannot be properly modeled such as when there are no standards for treatment, when affected populations have limited access to treatment, or when there are high rates of treatment dropout. CONCLUSION: Clinical trials should retain an important role in CER, particularly in cases of high disorder prevalence, large expected effect sizes, difficult-to-reach populations, or when examining sequential treatments or stepped-care algorithms. Progress in CER on mental health will require careful consideration of appropriate selection between clinical trials and nonexperimental designs and on allocation of research resources to optimally inform key treatment decisions for each patient.
OBJECTIVES: A large body of comparative effectiveness research (CER) focuses on the use of observational and quasi-experimental approaches. We sought to examine the use of clinical trials as a tool for CER, particularly in mental health. STUDY DESIGN AND SETTING: Examination of three ongoing randomized clinical trials in psychiatry addressing issues that would pose difficulties for nonexperimental CER methods. RESULTS: Existing statistical approaches to nonexperimental data appear insufficient to compensate for biases that may arise when the pattern of missing data cannot be properly modeled such as when there are no standards for treatment, when affected populations have limited access to treatment, or when there are high rates of treatment dropout. CONCLUSION: Clinical trials should retain an important role in CER, particularly in cases of high disorder prevalence, large expected effect sizes, difficult-to-reach populations, or when examining sequential treatments or stepped-care algorithms. Progress in CER on mental health will require careful consideration of appropriate selection between clinical trials and nonexperimental designs and on allocation of research resources to optimally inform key treatment decisions for each patient.
Authors: Emily Woltmann; Andrew Grogan-Kaylor; Brian Perron; Hebert Georges; Amy M Kilbourne; Mark S Bauer Journal: Am J Psychiatry Date: 2012-08 Impact factor: 18.112
Authors: Nathan C Sheets; Gregg H Goldin; Anne-Marie Meyer; Yang Wu; YunKyung Chang; Til Stürmer; Jordan A Holmes; Bryce B Reeve; Paul A Godley; William R Carpenter; Ronald C Chen Journal: JAMA Date: 2012-04-18 Impact factor: 56.272
Authors: Wayne Katon; Joan Russo; Elizabeth H B Lin; Julie Schmittdiel; Paul Ciechanowski; Evette Ludman; Do Peterson; Bessie Young; Michael Von Korff Journal: Arch Gen Psychiatry Date: 2012-05
Authors: Samuel M Galvagno; Elliott R Haut; S Nabeel Zafar; Michael G Millin; David T Efron; George J Koenig; Susan P Baker; Stephen M Bowman; Peter J Pronovost; Adil H Haider Journal: JAMA Date: 2012-04-18 Impact factor: 56.272